Virtu Financial’s RenovoRx RNXT Stock Holding History

Virtu Financial’s Portfolio RNXT Stock Details RNXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,208	Closed	-$64K	–	1953
2021 Q4	$64K	Buy	+13,208	New	+$78.4K	0.01%	1271

Other funds holding RNXT

LBC

Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Virtu Financial's RNXT Position: Q1 2022 in Review

Virtu Financial sold out of RenovoRx (RNXT) in Q1 2022, closing a stake of 13,208 shares — an estimated $64K sold.

Virtu Financial first reported a position in RNXT in Q4 2021 and held it in 1 quarter. The position peaked at $64K in Q4 2021. 12 funds tracked by Wall St. Rank hold RNXT as of Q1 2022.

Virtu Financial reported no remaining RenovoRx position as of Q1 2022 after selling out during the quarter.
Virtu Financial sold 13,208 RenovoRx shares in Q1 2022, an estimated $64K.
Virtu Financial first reported a position in RenovoRx in Q4 2021 and held it in 1 quarter.
Virtu Financial's RenovoRx position peaked at $64K in Q4 2021.
12 funds tracked by Wall St. Rank held RenovoRx as of Q1 2022.

Based on Virtu Financial's 13F filing for Q1 2022, filed 17 May 2022.